Alloy Wants Partners To Compete In Making Medicine, Not Technology Access

 
• By Joseph Haas

Alloy raises $75m in venture funding to further its mission of open-source antibody technology discovery. It also spins out portfolio companies, like ophthalmic-focused Broadwing.

Venture Capital Concept on the Mechanism of Metal Gears.
Alloy Therapeutics can expand its mission with a fresh infusion of $75m

More from Financing

More from Business